Economic impact of granulopoiesis stimulating agents on the management of febrile neutropenia.

Lyman, G H

Economic impact of granulopoiesis stimulating agents on the management of febrile neutropenia. [electronic resource] - Current opinion in oncology Jul 1998 - 291-6 p. digital

Publication Type: Journal Article; Review

1040-8746

10.1097/00001622-199807000-00003 doi


Colony-Stimulating Factors--economics
Cost-Benefit Analysis
Drug-Related Side Effects and Adverse Reactions
Fever--drug therapy
Granulocyte Colony-Stimulating Factor--economics
Granulocyte-Macrophage Colony-Stimulating Factor--economics
Humans
Neutropenia--complications